Browsing by Subject "Adipokines"

Sort by: Order: Results:

Now showing items 1-3 of 3
  • Chaudhry, Shafqat R.; Lendvai, Ilana S.; Muhammad, Sajjad; Westhofen, Philipp; Kruppenbacher, Johannes; Scheef, Lukas; Boecker, Henning; Scheele, Dirk; Hurlemann, Rene; Kinfe, Thomas M. (2019)
    Objective: To assay peripheral inter-ictal cytokine serum levels and possible relations with non-invasive vagus nerve stimulation (nVNS) responsiveness in migraineurs. Methods: This double-blinded, sham-controlled study enrolled 48 subjects and measured headache severity, frequency [headache days/month, number of total and mild/moderate/severe classified attacks/month], functional state [sleep, mood, body weight, migraine-associated disability] and serum levels of inflammatory markers [inter-ictal] using enzyme-linked immunoassays at baseline and after 2 months of adjunctive nVNS compared to sham stimulation and suitably matched controls. Results: No significant differences were observed at baseline and after 2 months for headache severity, total attacks/month, headache days/month and functional outcome [sleep, mood, disability] between verum and sham nVNS. However, the number of severe attacks/month significantly decreased in the verum nVNS group and circulating pro-inflammatory IL-1 beta was elevated significantly in the sham group compared to nVNS. Levels of anti-inflammatory IL-10 were significantly higher at baseline in both groups compared to healthy controls, but not at 2 months follow-up [p <0.05]. Concentrations of high-mobility group box-1 (HMGB-1), IL-6, tumor-necrosis factor-alpha (TNF-alpha), leptin, adiponectin, ghrelin remained unchanged [p > 0.05]. No severe device-/stimulation-related adverse events occurred. Conclusion: 2 months of adjunctive cervical nVNS significantly declined the number of severe attacks/month. Pro-inflammatory IL-1 beta plasma levels [inter-ictal] were higher in sham-treated migraine patients compared to verum nVNS. However, pro- [IL-6, HMGB-1, TNF-alpha, leptin] and anti-inflammatory [IL-10, adiponectin, ghrelin] mediators did not differ statistically. Profiling of neuroinflammatory circuits in migraine to predict nVNS responsiveness remains an experimental approach, which may be biased by pre-analytic variables warranting large-scale biobank-based systematic investigations [omics]. (C) 2019 Elsevier Inc. All rights reserved.
  • Savolainen-Peltonen, Hanna; Tikkanen, Matti J.; Mikkola, Tomi (2016)
    Rasva­kudos on eli­mis­tömme suu­rin endok­rii­ninen elin. Hormo­naa­linen sää­tely vai­kuttaa rasva­ku­doksen toi­mintaan ja kerty­miseen, jo­ka on eri­laista nai­silla ja mie­hillä se­kä ke­hon eri osissa. Rasva­kudos on myös merkit­tävä ste­roi­di­hor­monien läh­de, etenkin ­vaih­de­vuosien jäl­keen. Li­havuus ai­heuttaa rasva­ku­doksen toimin­nassa muu­toksia, muun muas­sa kroo­nisen tuleh­dus­reaktion. Häi­riöt rasva­ku­doksen toimin­nassa voi­vat ol­la yhtey­dessä kroo­nisten sai­rauksien, ku­ten rinta­syövän, ­dia­be­teksen se­kä sy­dän- ja veri­suo­ni­tautien syn­tyyn ja nii­den pahe­ne­miseen. Rasva­ku­doksen hormo­ni­toi­minnan ja rasva­so­lujen tuot­tamien välit­tä­jäai­neiden, adi­po­kiinien, tutki­minen aut­taa ymmär­tämään pa­remmin liha­vuuteen liit­tyvien sai­rauksien pato­fy­sio­logiaa ja luo uu­sia hoito­mah­dol­li­suuksia.
  • Tuomikoski, Pauliina; Savolainen-Peltonen, Hanna (2017)
    A vast majority of menopausal women suffer from vasomotor symptoms, such as hot flushes and night sweats, the mean duration of which may be up to 7-10 years. In addition to a decreased quality of life, vasomotor symptoms may have an impact on overall health. Vasomotor symptoms are associated with overactivity of the sympathetic nervous system, and sympathetic overdrive in turn is associated with metabolic syndrome, which is a known risk factor for cardiovascular disease. Menopausal hot flushes have a complex relationship to different features of the metabolic syndrome and not all data point towards an association between vasomotor symptoms and metabolic syndrome. Thus, it is still unclear whether vasomotor symptoms are an independent risk factor for metabolic syndrome. Research in this area is constantly evolving and we present here the most recent data on the possible association between menopausal vasomotor symptoms and the metabolic syndrome. (C) 2017 Elsevier B.V. All rights reserved.